4 stories mentioning ARDXUpdated just now
Every FINWIRES story that references ARDX, newest first.
Ardelyx (ARDX) has an average rating of buy and mean price target of $14.30, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $4.16, Change: $-0.72, Percent Change: -14.68%
Laura A Williams, Chief Patient Officer, on June 18, 2026, sold 81,898 shares in Ardelyx (ARDX) for $490,487. Following the Form 4 filing with the SEC, Williams has control over a total of 378,195 common shares of the company, with 378,195 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1437402/000186919426000008/xslF345X05/wk-form4_1782158491.xml
Michael Raab, Director, President & CEO, on May 15, 2026, sold 41,666 shares in Ardelyx (ARDX) for $261,612. Following the Form 4 filing with the SEC, Raab has control over a total of 1,800,145 common shares of the company, with 1,774,781 shares held directly and 25,364 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1437402/000132140226000009/xslF345X05/wk-form4_1779221004.xml
Michael Raab, Director, President & CEO, on April 15, 2026, sold 41,668 shares in Ardelyx (ARDX) for $261,954. Following the Form 4 filing with the SEC, Raab has control over a total of 1,820,978 common shares of the company, with 1,795,614 shares held directly and 25,364 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1437402/000132140226000008/xslF345X05/wk-form4_1776456264.xml
